desmondmorris node-tesseract up to 0.2.7 Command Builder lib/tesseract.js process image os command injection
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.9 | $0-$5k | 1.67+ |
Summary
A vulnerability was found in desmondmorris node-tesseract up to 0.2.7. It has been rated as critical. This affects the function process of the file lib/tesseract.js of the component Command Builder. Performing a manipulation of the argument image results in os command injection.
This vulnerability is reported as CVE-2026-117511. The attack is possible to be carried out remotely. Moreover, an exploit is present.
The project was informed of the problem early through an issue report but has not responded yet.
Details
A vulnerability classified as critical has been found in desmondmorris node-tesseract up to 0.2.7. This affects the function process of the file lib/tesseract.js of the component Command Builder. The manipulation of the argument image with an unknown input leads to a os command injection vulnerability. CWE is classifying the issue as CWE-78. The product constructs all or part of an OS command using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the intended OS command when it is sent to a downstream component. This is going to have an impact on confidentiality, integrity, and availability.
The advisory is shared at github.com. This vulnerability is uniquely identified as CVE-2026-117511. The exploitability is told to be easy. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. Technical details and a public exploit are known. MITRE ATT&CK project uses the attack technique T1202 for this issue.
The exploit is shared for download at github.com. It is declared as proof-of-concept. The project was informed of the problem early through an issue report but has not responded yet.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Vendor
Name
Version
Website
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.3VulDB Meta Temp Score: 6.9
VulDB Base Score: 7.3
VulDB Temp Score: 6.9
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Os command injectionCWE: CWE-78 / CWE-77 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Access: Public
Status: Proof-of-Concept
Download: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
10/27/2026 Advisory disclosed10/27/2026 VulDB entry created
10/27/2026 VulDB entry last update
Sources
Product: github.comAdvisory: 72
Status: Confirmed
CVE: CVE-2026-117511 (🔒)
GCVE (CVE): GCVE-0-2026-117511
GCVE (VulDB): GCVE-100-427077
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 10/27/2026 10:06Changes: 10/27/2026 10:06 (59)
Complete: 🔍
Submitter: ma1ware
Cache ID: 216::103
Submit
Accepted
- Submit #1024535: Desmond Morris node-tesseract 0.0.1-0.2.7 OS Command Injection (by ma1ware)
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.